Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol Treatment of Patients With Psoriatic Arthritis: Results of a Phase 3 Double-Blind Randomised Placebo-Controlled Study

Annals of the Rheumatic Diseases - United Kingdom

doi 10.1136/annrheumdis-2014-205198